Search Browse Earnings

Inmune Bio, Inc.

Nasdaq:INMB

Biological Products, (No Diagnostic Substances)·BOCA RATON, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Moss David J

CFO

Ellspermann Cory Randall

Revenue

$155,000

-58.6% YoY

FY 2024

Adj. EBITDA

—

Net Income

-$30.0M

-19360.0% margin

FY 2024

EPS (Diluted)

-$1.67

FY 2024

Stock Price

$1.31

-1.5%

2026-03-13

52W Range

$1.16 – $11.64

P/E Ratio

-0.8x

Market Cap

$34.8M

Cash

$35.8M

FY 2024

Total Debt

$9.7M

FY 2023

Net Cash

$26.2M

FY 2023

Enterprise Value

$8.7M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—